Budgetary impact analysis of reimbursement varenicline for the smoking-cessation treatment in patients with cardiovascular diseases, chronic obstructive pulmonary disease or type-2 diabetes mellitus: a national health system perspective
Guardado en:
Cedillo, S., et al., Budgetary impact analysis of reimbursement varenicline for the smoking-cessation treatment in patients with cardiovascular diseases, chronic obstructive pulmonary disease or type-2 diabetes mellitus: a national health system perspective. European Addiction Research, vol. 23, n. 1, 2017, p. 7-18.
Ref.
522200
Localización:
SIIS R.1142
Palabras clave:
Drogodependencias, Tabaquismo, Discapacidad, Enfermos, Cardiopatías, Diabetes, Enfermedades respiratorias, Enfermedades crónicas, Tratamiento médico, Fármacos, Efectos, Resultados, Literatura científica, Análisis coste eficacia, Calidad de la atención, Evaluación de servicios, España
Drogodependencias, Tabaquismo, Discapacidad, Enfermos, Cardiopatías, Diabetes, Enfermedades respiratorias, Enfermedades crónicas, Tratamiento médico, Fármacos, Efectos, Resultados, Literatura científica, Análisis coste eficacia, Calidad de la atención, Evaluación de servicios, España
Ejemplares similares: Budgetary impact analysis of reimbursement varenicline for the smoking-cessation treatment in patients with cardiovascular diseases, chronic obstructive pulmonary disease or type-2 diabetes mellitus: a national health system perspective
- REINFORCING BREATH CARBON MONOXIDE REDUCTIONS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- MOOD DISORDERS IN ELDERLY PATIENTS WITH CRONIC OBSTRUCTIVE PULMONARY DISEASE
- CARDIOVASCULAR DISEASE AND DIABETES IN PEOPLE WITH SEVERE MENTAL ILLNESS
- DIABETES MELLITUS AND OTHER CARDIOVASCULAR RISK FACTORS IN AN ELDERLY POPULATION
- THE EFFECT OF WALKING AIDS ON EXERCISE CAPACITY AND OXYGENATION IN ELDERLY PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- THE COSTS EFFECTIVENESS OF ANTIDEPRESSANTS FOR SMOKING CESSATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS